New CRISPR based gene-editing treatment targets root cause of kidney disease
A single-dose gene-editing therapy has shown it can correct the genetic cause of autosomal dominant polycystic kidney disease in preclinical...
A single-dose gene-editing therapy has shown it can correct the genetic cause of autosomal dominant polycystic kidney disease in preclinical...
This cross-sectional house-to-house study was conducted in Isfahan Province, Iran, between August and November 2022. The participants were recruited from...